<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kameda T</submitter><funding>MEXT | Japan Society for the Promotion of Science</funding><funding>Japan Agency for Medical Research and Development</funding><pagination>1309</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9709164</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>5(1)</volume><pubmed_abstract>Adult T-cell leukemia/lymphoma (ATL) is caused by human T-cell leukemia virus type 1 (HTLV-1). In addition to HTLV-1 bZIP factor (HBZ), a leukemogenic antisense transcript of HTLV-1, abnormalities of genes involved in TCR-NF-κB signaling, such as CARD11, are detected in about 90% of patients. Utilizing mice expressing CD4&lt;sup>+&lt;/sup> T cell-specific CARD11(E626K) and/or CD4&lt;sup>+&lt;/sup> T cell-specific HBZ, namely CARD11(E626K)&lt;sup>CD4-Cre&lt;/sup> mice, HBZ transgenic (Tg) mice, and CARD11(E626K)&lt;sup>CD4-Cre&lt;/sup>;HBZ Tg double transgenic mice, we clarify these genes' pathogenetic effects. CARD11(E626K)&lt;sup>CD4-Cre&lt;/sup> and HBZ Tg mice exhibit lymphocytic invasion to many organs, including the lungs, and double transgenic mice develop lymphoproliferative disease and increase CD4&lt;sup>+&lt;/sup> </pubmed_abstract><journal>Communications biology</journal><pubmed_title>CARD11 mutation and HBZ expression induce lymphoproliferative disease and adult T-cell leukemia/lymphoma.</pubmed_title><pmcid>PMC9709164</pmcid><funding_grant_id>17K09931</funding_grant_id><funding_grant_id>20ck0106538h0001</funding_grant_id><funding_grant_id>20ck0106409h0003</funding_grant_id><pubmed_authors>Kamiunten A</pubmed_authors><pubmed_authors>Tahira Y</pubmed_authors><pubmed_authors>Matsuda T</pubmed_authors><pubmed_authors>Koya J</pubmed_authors><pubmed_authors>Kitai Y</pubmed_authors><pubmed_authors>Kataoka K</pubmed_authors><pubmed_authors>Yokomizo-Nakano T</pubmed_authors><pubmed_authors>Kubota S</pubmed_authors><pubmed_authors>Kogure Y</pubmed_authors><pubmed_authors>Kameda T</pubmed_authors><pubmed_authors>Sugiyama M</pubmed_authors><pubmed_authors>Shide K</pubmed_authors><pubmed_authors>Marutsuka K</pubmed_authors><pubmed_authors>Ohshima T</pubmed_authors><pubmed_authors>Morishita D</pubmed_authors><pubmed_authors>Sashida G</pubmed_authors><pubmed_authors>Hidaka T</pubmed_authors><pubmed_authors>Kubuki Y</pubmed_authors><pubmed_authors>Ogawa S</pubmed_authors><pubmed_authors>Sekine M</pubmed_authors><pubmed_authors>Akizuki K</pubmed_authors><pubmed_authors>Shimoda K</pubmed_authors><pubmed_authors>Yoda A</pubmed_authors></additional><is_claimable>false</is_claimable><name>CARD11 mutation and HBZ expression induce lymphoproliferative disease and adult T-cell leukemia/lymphoma.</name><description>Adult T-cell leukemia/lymphoma (ATL) is caused by human T-cell leukemia virus type 1 (HTLV-1). In addition to HTLV-1 bZIP factor (HBZ), a leukemogenic antisense transcript of HTLV-1, abnormalities of genes involved in TCR-NF-κB signaling, such as CARD11, are detected in about 90% of patients. Utilizing mice expressing CD4&lt;sup>+&lt;/sup> T cell-specific CARD11(E626K) and/or CD4&lt;sup>+&lt;/sup> T cell-specific HBZ, namely CARD11(E626K)&lt;sup>CD4-Cre&lt;/sup> mice, HBZ transgenic (Tg) mice, and CARD11(E626K)&lt;sup>CD4-Cre&lt;/sup>;HBZ Tg double transgenic mice, we clarify these genes' pathogenetic effects. CARD11(E626K)&lt;sup>CD4-Cre&lt;/sup> and HBZ Tg mice exhibit lymphocytic invasion to many organs, including the lungs, and double transgenic mice develop lymphoproliferative disease and increase CD4&lt;sup>+&lt;/sup> </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-04-03T21:31:04.684Z</modification><creation>2025-04-03T21:31:04.684Z</creation></dates><accession>S-EPMC9709164</accession><cross_references><pubmed>36446869</pubmed><doi>10.1038/s42003-022-04284-x</doi></cross_references></HashMap>